Headlines Covid-19 Specialties Trending Feeds Videos

SOUTH SAN FRANCISCO, Calif., April 13, 2021 /PRNewswire/ — Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), today announced positive topline results from a multi-center, Phase 2